CLOMID

This brand name is authorized in Australia, Brazil, Estonia, France, Ireland, Japan, Malta, Netherlands, Nigeria, UK.

Active ingredients

The drug CLOMID contains one active pharmaceutical ingredient (API):

1	Clomifene UNII 1B8447E7YI - CLOMIPHENE CITRATE
	Clomifene is a non-steroidal agent which stimulates ovulation in a high percentage of appropriately selected anovulatory women. The ovulatory response to clomifene therapy is mediated through increased output of pituitary gonadotrophins, which in turn stimulates the maturation and endocrine activity of the ovarian follicle.
	Read more about Clomifene

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
CLOMID Tablet	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
G03GB02	Clomifene	G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03G Gonadotropins and other ovulation stimulants → G03GB Ovulation stimulants, synthetic
Discover more medicines within G03GB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	1211R
BR	Câmara de Regulação do Mercado de Medicamentos	525003101115414
EE	Ravimiamet	1753073
FR	Base de données publique des médicaments	65338028
GB	Medicines & Healthcare Products Regulatory Agency	196927, 23764
IE	Health Products Regulatory Authority	17833
JP	医薬品医療機器総合機構	2499009F1080
MT	Medicines Authority	AA1228/00901, AA770/03802
NG	Registered Drug Product Database	04-4969
Switch country to Nigeria in order to find specific presentations of CLOMID
NL	Z-Index G-Standaard, PRK	1538